JAGX Stock Summary and Trading Ideas (Jaguar Health | NASDAQ:JAGX)

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

Jaguar Health trades on the NASDAQ stock market under the symbol JAGX.

As of October 2, 2026, JAGX stock price declined to $3.66 with 498,726 million shares trading.

JAGX has a market cap of $1.90 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, JAGX traded as high as $416,579.20 and as low as $2.35.

JAGX has underperformed the market in the last year with a return of -99.7%, while the SPY ETF gained +16.1%. In the last 3 month period, JAGX fell short of the market, returning -92.0%, while SPY returned +3.6%. However, in the most recent 2 weeks JAGX has outperformed the stock market by returning +33.1%, while SPY returned +1.0%.

JAGX support price is $3.17 and resistance is $4.73 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that JAGX shares will trade within this expected range on the day.